Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option

被引：0
|
作者：
D Călugăru
M Călugăru
机构：
[1] University of Medicine Grigore T Popa,Department of Ophthalmology
[2] University of Medicine,Department of Ophthalmology
来源：
Eye | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：342 / 342
相关论文
共 50 条
  • [41] Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
    Ohara, Hiromi
    Harada, Yosuke
    Hiyama, Tomona
    Sadahide, Ayako
    Minamoto, Akira
    Kiuchi, Yoshiaki
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [42] Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
    Lim, Laurence S.
    Ng, Wei Yan
    Mathur, Ranjana
    Wong, Doric
    Wong, Edmund Y. M.
    Yeo, Ian
    Cheung, Chui Ming Gemmy
    Lee, Shu Yen
    Wong, Tien Yin
    Papakostas, Thanos D.
    Kim, Leo A.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 1715 - 1718
  • [43] THE EFFECT OF AGE ON AFLIBERCEPT (EYLEA) RESPONSE IN DIABETIC MACULAR EDEMA
    Ozsaygili, Cemal
    Duru, Zeynep
    Cicek, Ayse
    Ulusoy, Dondu Melek
    Demirtas, Atilim Armagan
    Duru, Necati
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (06): : 1038 - 1043
  • [44] Intravitreal aflibercept for diabetic macular edema: structural and functional improvements
    Zhang, Chuanhe
    Chen, Tianyu
    Jia, Ru
    Gong, Di
    Liu, Zhigao
    Wu, Changlong
    Shu, Xiangwen
    Han, Fangju
    Gong, Bin
    FRONTIERS IN MEDICINE, 2025, 12
  • [45] Aflibercept in the treatment of diabetic macular edema: a review and consensus paper
    Avitabile, Teresio
    Azzolini, Claudio
    Bandello, Francesco
    Boscia, Francesco
    De Falco, Sandro
    Fornasari, Diego
    Lanzetta, Paolo
    Mastropasqua, Leonardo
    Midena, Edoardo
    Ricci, Federico
    Staurenghi, Giovanni
    Varano, Monica
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (06) : 627 - 639
  • [46] Aflibercept therapy for diabetic macular edema resistant to ranibizumab and bevacizumab
    Karth, Peter
    Moshfeghi, Darius M.
    Leng, Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [47] AFLIBERCEPT AND NAVIGATED VERSUS CONVENTIONAL LASER IN DIABETIC MACULAR EDEMA
    Blindbaek, S.
    Peto, T.
    Grauslund, J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP28 - NP29
  • [48] Diabetic macular edema: Therapeutic options
    Kulkarni A.D.
    Ip M.S.
    Diabetes Therapy, 2012, 3 (1) : 1 - 14
  • [49] Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema
    Khattab, Abeer M.
    Hagras, Sherein M.
    AbdElhamid, AhmedHosni
    Torky, Magda A.
    Awad, Eman A.
    Abdelhameed, Ameera G.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (07) : 1373 - 1380
  • [50] Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema
    Abeer M. Khattab
    Sherein M. Hagras
    AhmedHosni AbdElhamid
    Magda A. Torky
    Eman A. Awad
    Ameera G. Abdelhameed
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1373 - 1380
12345